Tripped on Xenoport one too many times...fwiw...
Since its inception in 1999, XenoPort has raised over
$90 million in private venture funding. XenoPort's
investors include Alejandro Zaffaroni, Arch Ventures,
CMEA Ventures, Frazier & Co., HBM BioVentures AG,
Lilly BioVentures, Lombard Odier & Cie, Lotus
BioScience Ventures, Novartis BioVentures Ltd.,
Orbimed Advisors, Skyline Ventures, The Invus Group,
and Venrock Associates.
That may actually be the Novartis Venture Fund
venturefund.novartis.com
GlaxoSmithKline has a venture fund called SR One
Well for crying out loud, here is an article from
about a year ago at Signals:
signalsmag.com |
